There is rarely a universal route-to-market or commercial model in Consumer Healthcare.
Drug, medical device, nutritional supplement or another classification can materially change the growth path.
Classification influences product claims, evidence requirements and communication possibilities.
HCP influence, market access, stakeholders and channels shape how value is created.
Pricing, distribution, engagement and Route-to-Market need to reflect each market's specific conditions.
Prospect opportunity spaces, build platforms and bring propositions to life within regulatory and market constraints.
Assess attractiveness alongside regulatory pathway, ecosystem, channel structure and company right-to-win.